BusinessKaryopharm Publishes Preclinical and Phase 1 Clinical Data for Selinexor in Ovarian Cancer in Clinical Cancer Research PublicationBy Nasdaq OMXSep 28, 2016, 11:30 AM UTC
BusinessKLOX Technologies reports on its interim results from its ongoing clinical studies on LumiHeal™ for the treatment of chronic wounds and postsurgical scarringBy Nasdaq OMXSep 28, 2016, 10:00 AM UTC
BusinessMyoKardia Announces Pricing of Proposed Public Offering of Common StockBy Nasdaq OMXSep 27, 2016, 10:48 PM UTC
BusinessGalectin Therapeutics Announces Top-Line Data from Exploratory Phase 2a Pilot Trial (NASH-FX) with GR-MD-02 in NASH Patients with Advanced FibrosisBy Nasdaq OMXSep 27, 2016, 8:15 PM UTC
BusinessProQR Announces Clinical Data Presentations and Investor & Analyst Event at NACFCBy Nasdaq OMXSep 27, 2016, 11:00 AM UTC
BusinessMyoKardia Announces Proposed Public Offering of Common StockBy Nasdaq OMXSep 26, 2016, 8:48 PM UTC
BusinessTonix Pharmaceuticals to Present at 16th Annual Sachs Biotech in Europe ForumBy Nasdaq OMXSep 26, 2016, 1:00 PM UTC
BusinessPreliminary clinical results for Entia Biosciences, Inc.’s new, proprietary ErgoD2® medical food show an average increase in kidney filtration rate of approximately 10% for over 75% of test subjects, after only three monthsBy Nasdaq OMXSep 26, 2016, 12:30 PM UTC
